PMC Articles for MedGen (Select 1719176) - PMC

Links from MedGen

Items: 1 to 20 of 40

<< First< Prev

Page of 2

Select item 107815611.

Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations

Masafumi Shimoda, Yoshiaki Tanaka, Kozo Morimoto, Kozo Yoshimori, Ken Ohta

Intern Med. 2023 Dec 15; 62(24): 3601–3607. Published online 2023 Apr 21. doi: 10.2169/internalmedicine.1804-23

PMCID:: PMC10781561

Abstract Article PDF–345K

Select item 107491162.

Complete clinical remission of malignant peritoneal mesothelioma with systemic pemetrexed and bevacizumab in a patient with a BAP1 mutation

Jimmy Lee, Jordan Turetsky, Elham Nasri, Sherise C Rogers

BMJ Case Rep. 2023; 16(12): e255916. Published online 2023 Dec 22. doi: 10.1136/bcr-2023-255916

PMCID:: PMC10749116

Abstract Article PDF–1.4M

Select item 102347833.

Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review

Di Wu, Hongbing Zhang, Xin Li, Jinghao Liu, Minghui Liu, Hongyu Liu, Ming Dong, Jun Chen

Thorac Cancer. 2023 Jun; 14(16): 1520–1529. Published online 2023 Apr 23. doi: 10.1111/1759-7714.14876

PMCID:: PMC10234783

Abstract Article PDF–2.6M

Select item 97859404.

BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents

Sourat Darabi, David R. Braxton, Joanne Xiu, Benedito A. Carneiro, Jeff Swensen, Emmanuel S. Antonarakis, Stephen V. Liu, Rana R. McKay, David Spetzler, Wafik S. El-Deiry, Michael J. Demeure

Medicina (Kaunas) 2022 Dec; 58(12): 1818. Published online 2022 Dec 10. doi: 10.3390/medicina58121818

PMCID:: PMC9785940

Abstract Article PDF–969K

Select item 94752315.

Tumor suppressor effect of an antibody on xenotransplanted sarcomatoid mesothelioma cells

Masayoshi Hasegawa, Yuki Hanamatsu, Chiemi Saigo, Yusuke Kito, Tamotsu Takeuchi

Thorac Cancer. 2022 Sep; 13(18): 2566–2573. Published online 2022 Aug 2. doi: 10.1111/1759-7714.14591

PMCID:: PMC9475231

Abstract Article PDF–7.7M

Select item 90265676.

Mesothelioma in the age of “Omics”: Before and after The Cancer Genome Atlas

David T. Severson, Assunta De Rienzo, Raphael Bueno

J Thorac Cardiovasc Surg. Author manuscript; available in PMC 2022 Apr 22.

Published in final edited form as: J Thorac Cardiovasc Surg. 2020 Oct; 160(4): 1078–1083.e2. Published online 2020 May 29. doi: 10.1016/j.jtcvs.2020.02.141

PMCID:: PMC9026567

Abstract Article PDF–735K

Select item 88193147.

KRAS signaling in malignant pleural mesothelioma

Antonia Marazioti, Anthi C Krontira, Sabine J Behrend, Georgia A Giotopoulou, Giannoula Ntaliarda, Christophe Blanquart, Hasan Bayram, Marianthi Iliopoulou, Malamati Vreka, Lilith Trassl, Mario A A Pepe, Caroline M Hackl, Laura V Klotz, Stefanie A I Weiss, Ina Koch, Michael Lindner, Rudolph A Hatz, Juergen Behr, Darcy E Wagner, Helen Papadaki, Sophia G Antimisiaris, Didier Jean, Sophie Deshayes, Marc Grégoire, Özgecan Kayalar, Deniz Mortazavi, Şükrü Dilege, Serhan Tanju, Suat Erus, Ömer Yavuz, Pınar Bulutay, Pınar Fırat, Ioannis Psallidas, Magda Spella, Ioanna Giopanou, Ioannis Lilis, Anne‐Sophie Lamort, Georgios T Stathopoulos

EMBO Mol Med. 2022 Feb 7; 14(2): e13631. Published online 2021 Dec 13. doi: 10.15252/emmm.202013631

PMCID:: PMC8819314

Abstract Article PDF–12M

Select item 86047318.

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Patrick M. Forde, Valsamo Anagnostou, Zhuoxin Sun, Suzanne E. Dahlberg, Hedy L. Kindler, Noushin Niknafs, Thomas Purcell, Rafael Santana-Davila, Arkadiusz Z. Dudek, Hossein Borghaei, Mara Lanis, Zineb Belcaid, Kellie N. Smith, Archana Balan, James R. White, Christopher Cherry, I. K. Ashok Sivakumar, Xiaoshan M. Shao, Hok Yee Chan, Dipika Singh, Sampriti Thapa, Peter B. Illei, Drew M. Pardoll, Rachel Karchin, Victor E. Velculescu, Julie R. Brahmer, Suresh S. Ramalingam

Nat Med. 2021; 27(11): 1910–1920. Published online 2021 Nov 8. doi: 10.1038/s41591-021-01541-0

PMCID:: PMC8604731

Abstract Article PDF–10M

Select item 83404459.

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin

Wendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, Rodrigo Catalán, Luis Lara-Mejía, Suraj Samtani-Bassarmal, Andres F. Cardona, Jorge Mendoza-Desión, Daniel Hernández-Cueto, Altagracia Maldonado, Guillermina Baay-Guzmán, Sara Huerta-Yepes, Oscar Arrieta

BMC Cancer. 2021; 21: 892. Published online 2021 Aug 5. doi: 10.1186/s12885-021-08287-5

PMCID:: PMC8340445

Abstract Article PDF–1.2M

Select item 809862910.

Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen

Huatao Huang, Rui Reis, Yasuhiro Yonekawa, Jose Manuel Lopes, Paul Kleihues, Hiroko Ohgaki

Brain Pathol. 1999 Jan; 9(1): 33–42. Published online 2006 Apr 5. doi: 10.1111/j.1750-3639.1999.tb00207.x

PMCID:: PMC8098629

Summary PDF–166K

Select item 754333511.

A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma

Carl M. Gay, Yanhong Zhou, J. Jack Lee, Xi Ming Tang, Wei Lu, Ignacio I. Wistuba, Renata Ferrarotto, Don L. Gibbons, Bonnie S. Glisson, Merrill S. Kies, George R. Simon, John V. Heymach, Anne S. Tsao

Oncologist. 2020 Oct; 25(10): e1457–e1463. Published online 2020 Jul 19. doi: 10.1634/theoncologist.2020-0610

PMCID:: PMC7543335

Abstract Article PDF–2.5M

Select item 732766712.

Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma

Hossein Taghizadeh, Sabine Zöchbauer‐Müller, Robert M. Mader, Leonhard Müllauer, Thomas Klikovits, Thomas Bachleitner‐Hofmann, Mir A. Hoda, Gerald W. Prager

Thorac Cancer. 2020 Jul; 11(7): 1979–1988. Published online 2020 May 21. doi: 10.1111/1759-7714.13491

PMCID:: PMC7327667

Abstract Article PDF–142K

Select item 718069213.

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer

Peng Song, Xiaotong Zhang, Dongliang Yang, Hanping Wang, Xiaoyan Si, Li Zhang

Thorac Cancer. 2020 May; 11(5): 1216–1223. Published online 2020 Mar 17. doi: 10.1111/1759-7714.13376

PMCID:: PMC7180692

Abstract Article PDF–2.6M

Select item 649652214.

3‐O‐Methylfunicone, a metabolite produced by Penicillium pinophilum, modulates ERK1/2 activity, affecting cell motility of human mesothelioma cells

E. Buommino, I. Paoletti, A. De Filippis, R. Nicoletti, M. L. Ciavatta, S. Menegozzo, M. Menegozzo, M. A. Tufano

Cell Prolif. 2010 Apr; 43(2): 114–123. Published online 2010 Feb 26. doi: 10.1111/j.1365-2184.2010.00663.x

PMCID:: PMC6496522

Abstract Article PDF–886K

Select item 648757415.

Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers

Jasleen K. Grewal, Basile Tessier-Cloutier, Martin Jones, Sitanshu Gakkhar, Yussanne Ma, Richard Moore, Andrew J. Mungall, Yongjun Zhao, Michael D. Taylor, Karen Gelmon, Howard Lim, Daniel Renouf, Janessa Laskin, Marco Marra, Stephen Yip, Steven J. M. Jones

JAMA Netw Open. 2019 Apr; 2(4): e192597. Published online 2019 Apr 26. doi: 10.1001/jamanetworkopen.2019.2597

PMCID:: PMC6487574

Abstract Article

Select item 626058216.

Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma

K. G. Ewens, E. Lalonde, J. Richards-Yutz, C. L. Shields, A. Ganguly

BMC Cancer. 2018; 18: 1172. Published online 2018 Nov 26. doi: 10.1186/s12885-018-5079-x

PMCID:: PMC6260582

Abstract Article PDF–766K

Select item 613928517.

Clinical Implications of Real-Time Integrative Sequencing in Management of Patients with Suspected Germline BAP1 Mutations

Shayan Sengupta, Angela C. Weyand, Santhosh A. Upadhyaya, Yi-Mi Wu, Dan R. Robinson, Rajen J. Mody

J Pediatr Hematol Oncol. Author manuscript; available in PMC 2020 May 1.

Published in final edited form as: J Pediatr Hematol Oncol. 2019 May; 41(4): e263–e265. doi: 10.1097/MPH.0000000000001122

PMCID:: PMC6139285

Article PDF–85K

Select item 599393618.

Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion

Charu Aggarwal, Andrew R. Haas, Susan Metzger, Laura K. Aguilar, Estuardo Aguilar-Cordova, Andrea G. Manzanera, Gregoria Gómez-Hernández, Sharyn I. Katz, Evan W. Alley, Tracey L. Evans, Joshua M. Bauml, Roger B. Cohen, Corey J. Langer, Steven M. Albelda, Daniel H. Sterman

Mol Ther. 2018 May 2; 26(5): 1198–1205. Published online 2018 Feb 21. doi: 10.1016/j.ymthe.2018.02.015

PMCID:: PMC5993936

Abstract Article PDF–697K

Select item 592066019.

Low Incidence of Point Mutations in H‐, K‐ and N‐ras Oncogenes and p53 Tumor Suppressor Gene in Renal Cell Carcinoma and Peritoneal Mesothelioma of Wistar Rats Induced by Ferric Nitrilotriacetate

Yasuyuki Nishiyama, Hirofumi Suwa, Keisei Okamoto, Manabu Fukumoto, Hiroshi Hiai, Shinya Toyokuni

Jpn J Cancer Res. 1995 Dec; 86(12): 1150–1158. doi: 10.1111/j.1349-7006.1995.tb03308.x

PMCID:: PMC5920660

Abstract Article PDF–1.0M

Select item 545018220.

Calretinin as a blood-based biomarker for mesothelioma

Georg Johnen, Katarzyna Gawrych, Irina Raiko, Swaantje Casjens, Beate Pesch, Daniel G. Weber, Dirk Taeger, Martin Lehnert, Jens Kollmeier, Torsten Bauer, Arthur W. Musk, Bruce W. S. Robinson, Thomas Brüning, Jenette Creaney

BMC Cancer. 2017; 17: 386. Published online 2017 May 30. doi: 10.1186/s12885-017-3375-5

PMCID:: PMC5450182

Abstract Article PDF–836K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 40

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity